The clearance enables diagnostic-quality image viewing and advanced image processing directly within CliniComp’s New Era EHR with Native AI Solution Suite, expanding the unified enterprise platform by bringing diagnostic imaging, clinical workflows, and AI-driven decision support together in a single patient record.

Traditionally, imaging workflows have required clinicians to move between separate PACS and EHR systems. CliniComp’s FDA-cleared PACS Viewer eliminates that divide by enabling physicians to view, manipulate, and analyze diagnostic images directly within the patient chart, accelerating clinical decision-making and reducing workflow disruption.

“Healthcare organizations have spent decades managing separate clinical, imaging, and administrative systems,” said Chris Haudenschild, CEO of CliniComp. “With FDA clearance of our PACS Viewer, we’re extending our unified EHR strategy to enterprise imaging, allowing clinicians to access diagnostic-quality imaging, advanced image processing, patient data, and native AI capabilities from a single platform. This creates a more integrated and connected enterprise experience for providers and a stronger foundation for patient care.”